Paper Chase is a research database designed to offer abstracts of research articles published in journals that have a highly rated impact factor as determined by ISI Impact Factor and PageRank. Abstracts are organized by date, with the most recently published papers listed first. 

Paper Chase

141.

Comparison of ticagrelor with clopidogrel in patients with a planned invasive strategy for acute coronary syndromes (PLATO): a randomised double-blind study.

Lancet.
Cannon CP, Harrington RA, James S, Ardissino D, Becker RC, Emanuelsson H, Husted S, Katus H, Keltai M, Khurmi NS, Kontny F, Lewis BS, Steg PG, Storey RF, Wojdyla D, Wallentin L.
| Jan 23, 2010
142.

Effect of beta2-adrenergic receptor polymorphism on response to longacting beta2 agonist in asthma (LARGE trial): a genotype-stratified, randomised, placebo-controlled, crossover trial.

Lancet.
Wechsler ME, Kunselman SJ, Chinchilli VM, Bleecker E, Boushey HA, Calhoun WJ, Ameredes BT, Castro M, Craig TJ, Denlinger L, Fahy JV, Jarjour N, Kazani S, Kim S, Kraft M, Lazarus SC, Lemanske RF, Markezich A, Martin RJ, Permaul P, Peters SP, Ramsdell J, Sorkness CA, Sutherland ER, Szefler SJ, Walter MJ, Wasserman SI, Israel E, Engle LL.
| Nov 21, 2009
143.

Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor: an analysis of two randomised trials.

Lancet.
O'Donoghue ML, Braunwald E, Antman EM, Murphy SA, Bates ER, Rozenman Y, Michelson AD, Hautvast RW, Ver Lee PN, Close SL, Shen L, Mega JL, Sabatine MS, Wiviott SD.
| Sep 19, 2009
144.

Otamixaban for the treatment of patients with non-ST-elevation acute coronary syndromes (SEPIA-ACS1 TIMI 42): a randomised, double-blind, active-controlled, phase 2 trial.

Lancet.
Sabatine MS, Antman EM, Widimsky P, Ebrahim IO, Kiss RG, Saaiman A, Polasek R, Contant CF, McCabe CH, Braunwald E.
| Sep 5, 2009
145.

HPV vaccine for all.

Lancet.
Michels KB, zur Hausen H.
| Jul 25, 2009
146.

Multiple myeloma.

Lancet.
Raab MS, Podar K, Breitkreutz I, Richardson PG, Anderson KC.
| Jul 25, 2009
147.

Bladder cancer.

Lancet.
Kaufman DS, Shipley WU, Feldman AS.
| Jul 18, 2009
148.

Diabetes: finding "a clean well-lighted place".

Lancet.
Jacobson AM.
| May 23, 2009
149.

Gestational diabetes mellitus: an opportunity of a lifetime.

Lancet.
Bentley-Lewis R.
| May 23, 2009
150.

Painless jaundice with serial multi-organ dysfunction.

Lancet.
Khosroshahi A, Stone JR, Pratt DS, Deshpande V, Stone JH.
| Apr 25, 2009
151.

Can the polypill save the world from heart disease?

Lancet.
Cannon CP.
| Apr 18, 2009
152.

Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial.

Lancet.
Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto AM, Kastelein JJ, Koenig W, Libby P, Lorenzatti AJ, Macfadyen JG, Nordestgaard BG, Shepherd J, Willerson JT, Glynn RJ.
| Apr 4, 2009
153.

Caregiving: the odyssey of becoming more human.

Lancet.
Kleinman A.
| Jan 24, 2009
154.

Melatonin agonist tasimelteon (VEC-162) for transient insomnia after sleep-time shift: two randomised controlled multicentre trials.

Lancet.
Rajaratnam SM, Polymeropoulos MH, Fisher DM, Roth T, Scott C, Birznieks G, Klerman EB.
| Feb 7, 2009
155.

Perioperative beta blockers in patients having non-cardiac surgery: a meta-analysis.

Lancet.
Bangalore S, Wetterslev J, Pranesh S, Sawhney S, Gluud C, Messerli FH.
| Dec 6, 2008
156.

Violence and the role of illness narratives.

Lancet.
Westerhaus M, Panjabi R, Mukherjee J.
| Aug 30, 2008
157.

Treatment of extensively drug-resistant tuberculosis in Tomsk, Russia: a retrospective cohort study.

Lancet.
Keshavjee S, Gelmanova IY, Farmer PE, Mishustin SP, Strelis AK, Andreev YG, Pasechnikov AD, Atwood S, Mukherjee JS, Rich ML, Furin JJ, Nardell EA, Kim JY, Shin SS.
| Oct 18, 2008
158.

Promise of improving metabolic and lifestyle risk in practice.

Lancet.
Mozaffarian D.
| Jun 14, 2008
160.

Liver cirrhosis.

Lancet.
Schuppan D, Afdhal NH.
| Mar 8, 2008